Statements (39)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
blood test
|
| gptkbp:analyzes |
genetic mutations
protein biomarkers |
| gptkbp:benefit |
early detection increases survival rates
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:detects |
gptkb:cancer
colorectal cancer esophageal cancer liver cancer pancreatic cancer stomach cancer multiple cancer types cancer DNA mutations cancer protein biomarkers |
| gptkbp:developedBy |
gptkb:Johns_Hopkins_University
|
| gptkbp:firstPublished |
2018
|
| gptkbp:fundedBy |
gptkb:Johns_Hopkins_University
gptkb:National_Institutes_of_Health gptkb:John_Templeton_Foundation Lustgarten Foundation Virginia and D.K. Ludwig Fund for Cancer Research |
| gptkbp:goal |
non-invasive cancer screening
|
| gptkbp:hasResearchCenter |
gptkb:Bert_Vogelstein
gptkb:Nickolas_Papadopoulos |
| https://www.w3.org/2000/01/rdf-schema#label |
CancerSEEK
|
| gptkbp:limitation |
limited sensitivity for some cancers
not yet approved for clinical use requires further validation |
| gptkbp:publishedIn |
gptkb:science
|
| gptkbp:purpose |
early cancer detection
|
| gptkbp:relatedTo |
liquid biopsy
multi-cancer early detection tests |
| gptkbp:sensitivity |
varies by cancer type
|
| gptkbp:specificity |
greater than 99% in initial study
|
| gptkbp:status |
experimental
|
| gptkbp:technology |
liquid biopsy
|
| gptkbp:type |
blood
|
| gptkbp:bfsParent |
gptkb:Thrive_Earlier_Detection
|
| gptkbp:bfsLayer |
7
|